Home - Worldwide Healthcare Trust PLC

Worldwide Healthcare Trust (WWH) is an LSE-listed investment company seeking to provide investors with a globally diversified exposure to a portfolio of world-class healthcare companies.

The investment manager, OrbiMed, is the world’s largest dedicated healthcare investment company with an ever-growing team of sector specialists who are focused on identifying the world’s most innovative healthcare companies across a range of sub-sectors and geographies. The portfolio includes an exposure to some of the world’s largest pharmaceutical companies alongside those at the smaller end of the spectrum, such as early-stage biotechnology companies. All of them strive to address unmet medical needs and enhance human lives.

Find out more about us

A global growth opportunity

Diagram demonstrating Worldwide Health Organization’s 2025 Global Spending on Health Report, which states that global spending in 2023 was U.S.$10.6 trillion, up 28% from U.S.$8.3 trillion in 2018, split into 6 sectors and encompassed by artificial intelligence. Sector 1: Bio-pharma: 52 Novel FDA approvals in 2025; 57% Reduction in all-cause mortality for Lilly’s GLP-1 Foundayo; U.S.$73 billion Global Sales of GLP-1 medicines in 2025. Sector 2: Healthcare services: 1.4 billion people aged 60+ worldwide by 2030, a key driver for healthcare services; U.S.$10,000 expected annual savings for each uninsured GLP-1 user, through TrumpRx.gov consumer platform; 56.1 million American seniors who will get U.S.$50 per month in 2026 towards the cost of certain medication. Sector 3: Medical Technology: 3.1 million+ da Vinci robot procedures performed worldwide in 2025; 1,400+ FDA-listed AI-enabled medical devices since 1995; U.S.$1 billion+ FARAPULSE sales globally in its first year following US FDA approval. Sector 4: Diagnostics: 12% CAGR for Liquid Biopsy growth to 2030; 266,000 federally certified labs in the US; 2/3 US adults 45+ screened for colorectal cancer in 2023. Sector 5: Lifescience Tools: 14 billion Clinical lab tests and blood screens conducted in the US in 2025; 150+ FDA-approved targeted oncology agents in the US as of 2024, supporting demand for specialised manufacturing; U.S.$150 claimed cost per 30x human genome on emerging sequencing platforms, expanding the potential applications for genomics. Sector 6: Emerging markets: 30.5% of Global Pipelines from China-based biopharma companies; $138bn in China Out-licenced clinical assets; 2x increase in prescription drugs sales in India by 2030.

Annual General Meeting ("AGM")

The Worldwide Healthcare Trust’s AGM this year will be held at Barber-Surgeons' Hall, Monkwell Square, Wood St, Barbican, London EC2Y 5BL on Tuesday, 14 July 2026 from 12.30pm. In addition to the formal proceedings, there will be an opportunity to meet the Board and the Portfolio Manager and to receive an update on the Company’s strategy. A copy of the Trust's latest Annual Report (which includes the Notice of the AGM) can be found below.

For those investors who are not able to attend the meeting in person, a video recording of the Portfolio Manager's presentation will be uploaded to the Trust's website after the meeting. Shareholders can submit questions in advance by sending them to wwh@frostrow.com.

Worldwide Healthcare Trust (WWH) – Investor Update Webinar

Listen to Portfolio Managers, Trevor Polischuk and Sven H. Borho, provide investors with an update on WWH's recent performance and how the portfolio is positioned to try and take advantage of the current long-term opportunities across the global healthcare sector.

28 April 2026

More insights

Investor hub

Share Price

Share Price Information

Factsheets

10 Jun 2026

May 2026 Factsheet

Download document

30 Apr 2026

April 2026 Factsheet

Download document

Monthly Factsheets

Documents

05 Jun 2026

Annual Report 2026

Download document

View xhtml

12 Nov 2025

Half Year Report 2025

Download document

Important Documents

How to Invest

The Company’s shares are traded openly on the London Stock Exchange and can be purchased through a stockbroker, investment platform or other financial intermediary.

How to Invest